SCM
FATE icon

Soleus Capital Management’s Fate Therapeutics FATE Stock Holding History

Soleus Capital Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-870,000
Closed -$2.85M – 91
2024
Q2 		$2.85M Hold
870,000
– – 0.25% 73
2024
Q1 		$6.39M Buy
+870,000
New +$5.39M 0.56% 58
2022
Q4 		– Sell
-67,300
Closed -$1.51M – 78
2022
Q3 		$1.51M Sell
67,300
-127,100
-65% -$3.67M 0.2% 62
2022
Q2 		$4.82M Sell
194,400
-11,500
-6% -$317K 0.77% 40
2022
Q1 		$7.98M Buy
205,900
+198,100
+2,540% +$7.67M 1.23% 32
2021
Q4 		$456K Buy
+7,800
New +$442K 0.06% 64
2021
Q1 		– Sell
-6,830
Closed -$621K – 77
2020
Q4 		$621K Sell
6,830
-2,882
-30% -$179K 0.17% 60
2020
Q3 		$388K Sell
9,712
-23,288
-71% -$813K 0.21% 57
2020
Q2 		$1.13M Buy
+33,000
New +$984K 0.69% 37
2020
Q1 		– Sell
-11,400
Closed -$223K – 53
2019
Q4 		$223K Buy
+11,400
New +$181K 0.22% 48

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return